Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
32
days
Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer
AuthorsMaximilian Hellkamp; Simon Gertken; Jonas Buchloh; Julius-Leonard Hellwig; Lukas Ben Kowitzke; Ningjun Duan; Ilaria Gaspardo; Stefan Küffer; Michael Linnebacher; Philipp Ströbel; Matthias Wirth; Volker Ellenrieder; Stefan Rieken; Jochen Gaedcke; Michael Ghadimi; Jürgen Wienands; Günter Schneider; Melanie Spitzner; Marian Grade
Affiliations1. Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany; 2. Research Training Group (RTG) 2978, University Medical Center Göttingen, Göttingen, Germany; 3. Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany; 4. Molecular Oncology and Immunotherapy, Clinic of General Surgery, University Medical Center Rostock, Rostock, Germany; 5. CCC-N (Comprehensive Cancer Center Lower Saxony), Göttingen, Germany; 6. Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 7. Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany; 8. Department of Radiotherapy and Radiooncology, University Medical Center Göttingen, Göttingen, Germany; 9. Clinic for General and Visceral Surgery, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany; 10. Institute of Cellular and Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany; 11. Institute for Translational Cancer Research and Experimental Cancer Therapy, Technical University Munich, Munich, Germany
128
days
Cellular immunotherapy in melanoma: the next frontier in cancer treatment
AuthorsAnna-Lena Wien; Angeliki Stamtsis-Datsi
Affiliations1. Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
108
days
Loss of CSE couples with BRAF V600E to fuel thyroid cancer metastatic progression through zinc-dependent activation of the EMT machinery
AuthorsShichen Xu; Huixin Yu; Hongxun Wu; Zongfu Pan; Jiajie Xu; Yun Zhu; Botao Huang; Gangming Cai; Xiaobo Gu; Min Yang; Donghui Pan; Jie Pan; Jing Wu; Xian Cheng; Jiandong Bao; Li Zhang
Affiliations1. National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China; 2. Jiangsu Institute of Nuclear Medicine Jiangyuan Hospital of Jiangsu Province, Wuxi, China; 3. Department of Pharmacy, Center for Clinical Pharmacy, Cancer Center, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, China; 4. Department of Head and Neck Surgery, Otolaryngology & Head and Neck Center, Cancer Center, Zhejiang Provincial People’s Hospital, Hangzhou, China; 5. Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing, China; 6. School of Life Sciences, Nanjing Medical University, Changzhou, China; 7. School of Life science and Technology, Southeast University, Nanjing, China
103
days
Alkylating agents activate an SLFN11-dependent vulnerability that confers PARP-1 inhibitor sensitivity in kidney cancer
AuthorsChenliang Wang; Ming Zhu; Lei Bao; Vanina Toffessi Tcheuyap; James Brugarolas; Weibo Luo; Yingfei Wang
Affiliations1. Department of Pathology, UT Southwestern Medical Center, Dallas, USA; 2. Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, USA; 3. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, USA; 4. Department of Pharmacology, UT Southwestern Medical Center, Dallas, USA; 5. Department of Neurology, UT Southwestern Medical Center, Dallas, USA; 6. Peter O’Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, USA
81
days
NOTCH3 regulates myofibroblastic CAF differentiation via the P62–ROS signaling axis to promote bladder cancer progression
AuthorsDing Hu; Chengquan Shen; Changxue Liu; Fei Xie; Xinning Wang; Hexiang Wang; Yunqing Chen; Xinzhao Zhao; Ruize Qin; Cheng Li; Huaixi Ge; Jianhang Zhu; Zhengze Xi; Yonghua Wang
Affiliations1. Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China; 2. Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China; 3. Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China; 4. Urinary Diseases Clinical Medical Research Center of Qingdao, Qingdao, China; 5. Shandong Province Medical and Health Key Laboratory of Urology, Qingdao, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days